StockData
Rogers Corp logo

Rogers Corp (ROG) stock analysis

ROGNYSEPlastic Materials, Synth Resins & Nonvulcan ElastomersFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/3036% above fair value
$130.89+2.61 (+2.03%)

Close on Nov 11, 2026Market cap $2.33BP/E 51.7Yield –

StockData Score

Prices as of Nov 11, 2026How the score works

Value1Growth2Performance2Health6Dividend0

Mixed11 of 30 checks passed

Rogers passes 11 of the 30 checks behind our score; 8 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation
1/6
Growth
2/6
Past performance
2/6
Financial health
6/6
Dividend
0/6

What stands out

  • No debt

    Rogers has no borrowings on its latest balance sheet.

  • Interest well covered

    No meaningful interest expense to cover.

  • Debt covered by cash flow

    There is no debt to cover.

  • Low bankruptcy risk

    The Altman Z-score is 8.09; above 3 is the safe zone and below 1.8 the distress zone.

What to watch

  • Margin of safety under 20%

    The price is 36.0% above fair value, so there is no margin of safety.

  • Trading above fair value

    The share price of $130.89 is above our fair value estimate of $96.27.

  • Return on equity under 15%

    Return on equity was 3.7% over the last twelve months and averaged 4.4% over five years; we look for 15% on both.

  • Return on capital under 10%

    Return on invested capital was 4.2%, below the 10% that usually covers the cost of capital.

Valuation1/6

  • P/E above its 5-year median

    Rogers's P/E of 51.7 is above its own 5-year median of 38.6.

  • P/E above the industry

    Rogers's P/E of 51.7 is above the Chemicals and Allied Products median of 25.2.

  • EV/EBITDA below its 5-year median

    Rogers's EV/EBITDA of 17.1 is below its 5-year median of 17.2.

  • P/B above the industry

    Rogers's price-to-book of 1.91 is above the Chemicals and Allied Products median of 1.50.

  • Trading above fair value

    The share price of $130.89 is above our fair value estimate of $96.27.

  • Margin of safety under 20%

    The price is 36.0% above fair value, so there is no margin of safety.

Growth2/6

  • Revenue growing under 10% a year

    Revenue grew -5.8% a year over the last three fiscal years, short of the 10% we look for.

  • EPS growth over 3 years

    Needs positive EPS three years ago and today.

  • Earnings acceleration

    Needs positive net income now, a year ago and five years ago.

  • Growing faster than the industry

    Revenue grew 6.7% over the last twelve months; the Chemicals and Allied Products median is 5.7%.

  • Guidance lowered

    Rogers lowered its 2026 Capital Expenditures outlook on Jul 28, 2026.

  • Gross margin improving

    Gross margin was 32.7% over the last twelve months, against 31.8% a year earlier.

Past performance2/6

  • Return on equity under 15%

    Return on equity was 3.7% over the last twelve months and averaged 4.4% over five years; we look for 15% on both.

  • Return on capital under 10%

    Return on invested capital was 4.2%, below the 10% that usually covers the cost of capital.

  • Return on equity below the industry

    Rogers's return on equity of 3.7% is below the Chemicals and Allied Products median of 3.7%.

  • Earnings over 5 years

    Needs positive net income five years ago and in the latest year.

  • Net margin above its 5-year average

    Net margin was 5.3% over the last twelve months, against a 5-year average of 5.1%.

  • Net margin above the industry

    Rogers's net margin of 5.3% is above the Chemicals and Allied Products median of 0.8%.

Financial health6/6

  • No debt

    Rogers has no borrowings on its latest balance sheet.

  • Debt not rising

    With no debt today, leverage cannot have risen.

  • Debt covered by cash flow

    There is no debt to cover.

  • Interest well covered

    No meaningful interest expense to cover.

  • Short-term assets cover short-term debts

    Current assets are 4.14 times current liabilities.

  • Low bankruptcy risk

    The Altman Z-score is 8.09; above 3 is the safe zone and below 1.8 the distress zone.

Dividend0/6

  • No dividend

    Rogers has not paid a dividend in the last twelve months.

  • Yield against Treasuries

    No dividend.

  • Yield against the market

    No dividend.

  • Dividend stability

    No dividend.

  • Earnings cover

    No dividend.

  • Cash-flow cover

    No dividend.

Scores of similar companies

Fair value

How we estimate it

Our estimate per share

$96.27

The share price is 36% above this estimate.

20%+ below
Near fair value
20%+ above
$130.89Price$96.27Fair value
MethodMultiple usedOwn 5Y medianIndustry medianValue per shareWeight
P/E32.0×38.6×25.2×$80.8540%
EV/EBITDA16.9×17.2×16.6×$129.3135%
P/B1.7×1.9×1.5×$116.4510%
Earnings power9.2% cost of equity––$46.8315%
Fair value$96.27100%

Valuation over time

Using the earnings and balance sheet published at each date, not today's.

  • P/E at month end
  • Own 5-year median 38.6
  • Chemicals and Allied Products median 25.2

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

Low risk

Average value traded per day
$32.74M
Value traded per 1% price move
$12.04M

Downside

Medium risk

Typical loss in a bad month
21.2%
Volatility (annualized)
46%
Sharpe ratio, 1 year
1.07
Beta to the S&P 500 (5Y)
0.86

Typical bad-month loss, week by week

25%: high

Margins

Share of revenue, fiscal years 2011 to 2025

Gross margin

31.7%−4.7 pts over 5 years

Operating margin

-5.6%−13.9 pts over 5 years

Net margin

-7.6%−13.9 pts over 5 years

See a number that looks wrong?